Nkx2.1 transcription factor in lung cells and a transforming growth factor‐β1 heterozygous mouse model of lung carcinogenesis
Authors:
- 28 May 2004
- journal article
- Published by Wiley in Molecular Carcinogenesis
- Vol. 40 (4) , 212-231
Abstract
The Nkx2.1 homeobox gene and transforming growth factor‐β1 (TGF‐β1) are essential for organogenesis and differentiation of the mouse lung. NKX2.1 is a marker of human lung carcinomas, but it is not known whether this gene participates in early tumorigenesis. Addition of TGF‐β1 to TGF‐β1‐responsive nontumorigenic mouse lung cells cotransfected with a NKX2.1Luc luciferase reporter and either a Sp1 or Sp3 plasmid showed a significant increase or decrease, respectively, in NKX2.1Luc transcription. Cotransfection of Sp3 and dominant‐negative TGF‐β type II receptor plasmids negated the effect of Sp1. Cotransfected Sp1 plasmid with either dominant‐negative Smad2 or Smad3 or Smad4 plasmids significantly decreased NKX2.1Luc transcription. Electrophoretic mobility shift assays revealed binding of Sp1 and Smad4 to the NKX2.1 promoter. With a TGF‐β1 heterozygous mouse model, Nkx2.1 mRNA and protein in lungs of TGF‐β1 heterozygous mice were significantly lower compared to wildtype (WT) littermates. Competitive reverse transcription (RT)‐polymerase chain reaction (PCR) and immunostaining showed that Nkx2.1 mRNA and protein decreased significantly in adenomas and adenocarcinomas compared to normal lung tissue. Our in vitro data showed that regulation of Nkx2.1 by TGF‐β1 occurs through TGF‐β type II receptor and Smad signaling, with Sp1 and Sp3 in lung cells. Our in vivo data showed reduced Nkx2.1 in lungs of TGF‐β1 heterozygous mice compared to WT mice, that is detectable in adenomas, and that is further reduced in carcinogenesis, and that correlates with reduction of Sp1, Sp3, and Smads in lung adenocarcinomas. Our findings suggest that reduced Nkx2.1 and TGF‐β1 signaling components may contribute to tumorigenesis in the lungs of TGF‐β1 heterozygous mice. Published 2004 Wiley‐Liss, Inc.Keywords
This publication has 67 references indexed in Scilit:
- Regulation of the human transforming growth factor β type II receptor gene promoter by novel Sp1 sitesOncogene, 2001
- Enhanced tumorigenesis and reduced transforming growth factor-? type II receptor in lung tumors from mice with reduced gene dosage of transforming growth factor-?1Molecular Carcinogenesis, 2000
- Reduction in transforming growth factor-β type II receptor in mouse lung carcinogenesisMolecular Carcinogenesis, 1998
- Structure and expression of the promoter for the R4/ALK5 human type I transforming growth factor-β receptor: regulation by TGF-βBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1996
- Characterization of the Promoter Region of the Human Transforming Growth Factor-β Type II Receptor GeneJournal of Biological Chemistry, 1995
- Signaling Activity of Homologous and Heterologous Transforming Growth Factor-β Receptor Kinase ComplexesJournal of Biological Chemistry, 1995
- Maternal Rescue of Transforming Growth Factor-β 1 Null MiceScience, 1994
- Cloning of a TGF$beta; type I receptor that forms a heteromeric complex with the TGF$beta; type II receptorCell, 1993
- Regulation of the transforming growth factor-β1 and -β3 promoters by transcription factor SplGene, 1993
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976